Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2023-06-29 00:00:00 ET · period of report 2023-06-27 · accession 0000899243-23-016705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-29 | 2023-06-27 | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $5.49 | +1.74M | 7.12M | +32% | +$9.55M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-27 | P | A | 1,740,000 | $5.49 | 7,117,839 | D | — | — |